
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Pregabalin: Difference between revisions
Jump to navigation
Jump to search
>Oskykins m Text replacement - "PW's dosage information is a summary of data gathered from users and resources. It is not a recommendation and should be verified with other sources for accuracy." to "PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy." |
>Isaak Adjust the total such that it is the sum of onset, comeup, peak and offset for the min and max respectively. |
||
(40 intermediate revisions by 16 users not shown) | |||
Line 1: | Line 1: | ||
{{SubstanceBox | {{SubstanceBox | ||
<!-- | <!-- Special Parameters --> | ||
|MaterialTable_MaxWidth= | |displayClasses={{{displayClasses|}}} | ||
|MaterialTable_MaxWidth=250px | |||
|MaterialTable_Title={{PAGENAME}} | |MaterialTable_Title={{PAGENAME}} | ||
Line 10: | Line 11: | ||
|ModuleStructure=true | |ModuleStructure=true | ||
|ModuleNomenclature=true | |ModuleNomenclature=true | ||
|ModuleClassMembership=true | |||
|ModuleROA=true | |ModuleROA=true | ||
Line 31: | Line 33: | ||
<!-- Structure --> | <!-- Structure --> | ||
|MolecularStructureCaption= | |MolecularStructureCaption=Molecular structure of pregabalin | ||
|SkeletalImageFile=File: | |SkeletalImageFile=File:Pregabalin.svg | ||
|SkeletalImageWidth= | |SkeletalImageWidth=245px | ||
|3DImageFile= | |3DImageFile= | ||
|3DImageWidth= | |3DImageWidth= | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=Lyrica, Nervalin | |NameCommon=[[common name::Pregabalin]], [[common name::Lyrica]], [[common name::Nervalin]] | ||
|NameSubstitution= | |NameSubstitution=3-Isobutyl GABA | ||
|NameSystematic=(S)-3-( | |NameSystematic=(S)-3-(Aminomethyl)-5-methylhexanoic acid | ||
<!-- Class Membership --> | |||
|EffectClass=[[psychoactive class::Depressant]] | |||
|ChemicalClass=[[chemical class::Gabapentinoid]] | |||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
Line 46: | Line 52: | ||
|SmokedROA=false | |SmokedROA=false | ||
|SmokedROA_Collapsed=true | |SmokedROA_Collapsed=true | ||
|SmokedROA_Caption= | |SmokedROA_Caption= | ||
|SmokedROA_Bioavailability= | |SmokedROA_Bioavailability= | ||
|SmokedROA_Threshold=< x mg | |SmokedROA_Threshold=< x mg | ||
Line 59: | Line 65: | ||
|SmokedROA_Peak=x minutes | |SmokedROA_Peak=x minutes | ||
|SmokedROA_Offset=x hours | |SmokedROA_Offset=x hours | ||
| | |SmokedROA_Aftereffects=x hours | ||
|OralROA=true | |OralROA=true | ||
|OralROA_Collapsed=false | |OralROA_Collapsed=false | ||
|OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation and | |OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation.<br>'''This dosage and duration information has been sourced from [http://drugs.tripsit.me/pregabalin TripSit]''' | ||
|OralROA_Bioavailability=90% | |OralROA_Bioavailability=[[Oral min bioavailability::]] ~[[Oral max bioavailability::90]]%<ref name="Bockbrader2010">{{cite journal | vauthors=((Bockbrader, H. N.)), ((Radulovic, L. L.)), ((Posvar, E. L.)), ((Strand, J. C.)), ((Alvey, C. W.)), ((Busch, J. A.)), ((Randinitis, E. J.)), ((Corrigan, B. W.)), ((Haig, G. M.)), ((Boyd, R. A.)), ((Wesche, D. L.)) | journal=The Journal of Clinical Pharmacology | title=Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers | volume=50 | issue=8 | pages=941–950 | date= August 2010 | url=http://doi.wiley.com/10.1177/0091270009352087 | issn=00912700 | doi=10.1177/0091270009352087}}</ref> | ||
|OralROA_Threshold=[[Oral threshold dose:: | |OralROA_Threshold=[[Oral threshold dose::50]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose:: | |OralROA_Light=[[Oral min light dose::50]] - [[Oral max light dose::225]] mg | ||
|OralROA_Common=[[Oral min common dose:: | |OralROA_Common=[[Oral min common dose::225]] - [[Oral max common dose::600]] mg | ||
|OralROA_Strong=[[Oral min strong dose::600]] - [[Oral max strong dose::900]] mg | |OralROA_Strong=[[Oral min strong dose::600]] - [[Oral max strong dose::900]] mg | ||
|OralROA_Heavy= | |OralROA_Heavy= [[Oral heavy dose::900]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
|OralROA_Duration=[[Oral min total time:: | |OralROA_Duration=[[Oral min total time::9]] - [[Oral max total time::17]] [[Oral total time units::hours]] | ||
|OralROA_Onset=[[Oral min onset time:: | |OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::45]] [[Oral onset time units::minutes]] | ||
|OralROA_Peak= | |OralROA_Comeup=[[Oral min comeup time::1]] - [[Oral max comeup time::2]] [[Oral comeup time units::hours]] | ||
|OralROA_Offset= | |OralROA_Peak=[[Oral min peak time::4]] - [[Oral max peak time::6]] [[Oral peak time units::hours]] | ||
| | |OralROA_Offset=[[Oral min offset time::4]] - [[Oral max offset time::8]] [[Oral offset time units::hours]] | ||
|OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max afterglow time::10]] [[Oral afterglow time units::hours]] | |||
|RectalROA=true | |||
|RectalROA_Collapsed=true | |||
|RectalROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation.<br>'''This dosage and duration information has been sourced from [http://drugs.tripsit.me/methamphetamine TripSit]''' | |||
|RectalROA_Bioavailability=~99% | |||
|RectalROA_Threshold=< [[Rectal threshold dose::40]] [[Rectal dose units::mg]] | |||
|RectalROA_Light=[[Rectal min light dose::40]] - [[Rectal max light dose::200]] mg | |||
|RectalROA_Common=[[Rectal min common dose::200]] - [[Rectal max common dose::450]] mg | |||
|RectalROA_Strong=[[Rectal min strong dose::450]] - [[Rectal max strong dose::600]] mg | |||
|RectalROA_Heavy=[[Rectal heavy dose::600]] mg+ | |||
|RectalROA_TimelineFile= | |||
|RectalROA_TimelineWidth=280px | |||
|RectalROA_Duration=[[Rectal min total time::5]] - [[Rectal max total time::8]] [[Rectal total time units::hours]] | |||
|RectalROA_Onset=[[Rectal min onset time::15]] - [[Rectal max onset time::30]] [[Rectal onset time units::minutes]] | |||
|RectalROA_Comeup=[[Rectal min comeup time::30]] - [[Rectal max comeup time::120]] [[Rectal comeup time units::minutes]] | |||
|RectalROA_Peak=[[Rectal min peak time::2]] - [[Rectal max peak time::3]] [[Rectal peak time units::hours]] | |||
|RectalROA_Offset=[[Rectal min offset time::3]] - [[Rectal max offset time::5]] [[Rectal offset time units::hours]] | |||
|RectalROA_Aftereffects=[[Rectal min afterglow time::6]] - [[Rectal max afterglow time::12]] [[Rectal afterglow time units::hours]] | |||
}} | }} |
Latest revision as of 07:26, 13 October 2022
SubstanceBox/Pregabalin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common names | Pregabalin, Lyrica, Nervalin | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Substitutive name | 3-Isobutyl GABA | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Systematic name | (S)-3-(Aminomethyl)-5-methylhexanoic acid | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Psychoactive class | Depressant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chemical class | Gabapentinoid | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
- ↑ Bockbrader, H. N., Radulovic, L. L., Posvar, E. L., Strand, J. C., Alvey, C. W., Busch, J. A., Randinitis, E. J., Corrigan, B. W., Haig, G. M., Boyd, R. A., Wesche, D. L. (August 2010). "Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers". The Journal of Clinical Pharmacology. 50 (8): 941–950. doi:10.1177/0091270009352087. ISSN 0091-2700.